For GHK-Cu FDA approval, pharmaceutical products must meet strict requirements for impurity control throughout the entire shelf life
10.1186/1476-511X-10-127 66
Wu S, Chai S, Yang J, Cai T, Xu Y, Yang Z, Zhang Y, Ji L, Sun F, Zhan S (2017) Gastrointestinal adverse events of dipeptidyl peptidase 4 inhibitors in type 2 diabetes: a systematic review and network meta-analysis
The ex vivo fluorescence imaging of organs and the tumor taken from 5 h post-injection similarly showed that the intensity of the fluorescence signal of the tumor was more than ten times higher than that of other organs, such as the liver and kidney (Fig
Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer